ASR Nederland N.V

ASRNL

Equity

ISIN NL0011872643 / Valor 32745332

Euronext - Euronext Amsterdam (2026-10-02)

EUR 71.48+0.68%

ASR Nederland N.V
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

ASR Nederland N.V., operating under the a.s.r. brand, is a prominent Dutch insurance and financial services company. It provides a comprehensive range of products across various sectors including property and casualty (P&C) insurance for all customer segments, defined benefit pension products tailored for the commercial market, and individual life insurance options such as term life and annuity. Beyond insurance, a.s.r. extends its offerings to the banking sector, catering to retail clients with mortgages, savings, and investment products. Since May 2016, the company has leveraged its expertise in asset management to serve institutional clients, indicating a strategic expansion of its services. This diversification of products and services underscores a.s.r.'s commitment to meeting the broad financial needs of its clientele, ranging from individual consumers to large institutions.

Summarized from source with an LLMView SourceSector: Finance

Headline financials

Operating result: €901m (+9.8%); Net result: €809m (large increase vs HY 2025). Operating return on equity 15.4% (HY 2025: 14.2%). Total equity €10,489m (up 3.6%).

Capital strength & distributions

Solvency II ratio 222% (31‑Dec‑2025: 218%). Organic capital creation €773m (+7.3%). Interim dividend €1.39/share (+9.4%) and completion of the €175m share buyback in H1 2026.

Commercial performance

Premiums: P&C & Disability premiums received €2,709m (organic growth +6.0%). Total premium & DC inflow declined to €6,394m (‑26.7%) driven by fewer pension buy-outs versus HY 2025. Pension DC AuM €34.1bn (+€4.1bn).

Segment results

Life operating result €689m (+11.6%), driven by higher investment margin and lower UFR drag. Non‑life operating result €268m (+4.6%) with a combined ratio (excl. Health) 91.6% (within/better than target range). Fee-based businesses operating result €115m (+32.1%) helped by the HumanTotalCare acquisition.

Costs and one-offs

Operating expenses €815m (+16.6%), reflecting the inclusion of HumanTotalCare and investments in technology/AI. Adjustment items included a positive investment-related adjustment of €277m contributing to result before tax.

Business mix & lending

Mortgage origination €3.6bn (HY 2025: €4.5bn) reflecting a 'value over volume' approach; Assets under management for third parties €41.6bn (+11.7%).

Sustainability & non-financial progress

Investment portfolio carbon footprint down 28.5% vs 2023 base (already beyond the 2030 target); impact investments 10.1% of portfolio; Net Promoter Score (interactions) 27 (up vs HY 2025) and sustainable reputation 45% (above target range).

Corporate actions & outlook

Integration of Aegon Nederland completed in H1 (life entities merged in July); acquisition of Bovemij insurance activities announced (July) to strengthen non‑life/mobility position. Management expects to present refreshed 2027–2029 strategy at Capital Markets Day on 1 Dec 2026.

Summarized from source with an LLMView Source

Key figures

24.5%1Y

101%3Y

81.1%5Y

Performance

15.8%1Y

21.2%3Y

22.6%5Y

Volatility